Literature DB >> 16004748

Hormone replacement therapy: limited response in the UK to the new evidence.

Joy Townsend, Kiran Nanchahal.   

Abstract

Mesh：

Year:  2005        PMID： 16004748      PMCID： PMC1472792     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

1.  Hormone replacement therapy: assessment of present use, costs, and trends.

Authors:  J Townsend
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

2.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

3.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

4.  Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

Authors: 
Journal:  BJOG       Date:  2002-12       Impact factor: 6.531
  4 in total
  4 in total

1.  Effect of clinical trial publicity on HRT prescribing in Ireland.

Authors:  C Usher; M Teeling; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2006-01-24       Impact factor: 2.953

2.  New evidence rekindles the hormone therapy debate.

Authors:  Noreen Goldman
Journal:  J Fam Plann Reprod Health Care       Date:  2010-04

3.  Exercise participation, body mass index, and health-related quality of life in women of menopausal age.

Authors:  Amanda Daley; Christine Macarthur; Helen Stokes-Lampard; Richard McManus; Sue Wilson; Nanette Mutrie
Journal:  Br J Gen Pract       Date:  2007-02       Impact factor: 5.386

4.  Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

Authors:  Joanna Watson; Lesley Wise; Jane Green
Journal:  Eur J Clin Pharmacol       Date:  2007-06-28       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.